UK bioceramic maker targets device market:
This article was originally published in Clinica
Executive Summary
Biocomposites has separated from its parent company in a £1.4 million management buyout, assisted by venture capital funding from 3i. Biocomposites was founded as a subsidiary of Jesse Shirley, a porcelain material manufacturer, in 1993 to fulfill demand for high purity ceramic products. The company aims to target demand for resorbable materials in the device market.